vs
奔特力系统（BSY）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
奔特力系统的季度营收约是Ultragenyx Pharmaceutical Inc.的1.9倍（$391.6M vs $207.3M），奔特力系统净利率更高（15.0% vs -62.0%，领先77.0%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 11.9%），奔特力系统自由现金流更多（$136.2M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 7.7%）
奔特力系统是总部位于美国的软件开发企业，面向全球基础设施的设计、建造及运营全周期，提供软件产品授权、销售及相关技术支持服务。旗下产品覆盖建筑、工厂、土木、地理空间等领域，广泛应用于建筑工程施工及运营场景，支撑各类大型建成资产的全生命周期管理。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
BSY vs RARE — 直观对比
营收规模更大
BSY
是对方的1.9倍
$207.3M
营收增速更快
RARE
高出14.0%
11.9%
净利率更高
BSY
高出77.0%
-62.0%
自由现金流更多
BSY
多$236.9M
$-100.8M
两年增速更快
RARE
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $391.6M | $207.3M |
| 净利润 | $58.6M | $-128.6M |
| 毛利率 | 81.9% | — |
| 营业利润率 | 20.0% | -54.7% |
| 净利率 | 15.0% | -62.0% |
| 营收同比 | 11.9% | 25.9% |
| 净利润同比 | 17.1% | 3.5% |
| 每股收益（稀释后） | $0.17 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BSYRARE
| Q4 25 | $391.6M | $207.3M | ||
| Q3 25 | $375.5M | $159.9M | ||
| Q2 25 | $364.1M | $166.5M | ||
| Q1 25 | $370.5M | $139.3M | ||
| Q4 24 | $349.8M | $164.6M | ||
| Q3 24 | $335.2M | $139.5M | ||
| Q2 24 | $330.3M | $147.0M | ||
| Q1 24 | $337.8M | $108.8M |
净利润BSYRARE
| Q4 25 | $58.6M | $-128.6M | ||
| Q3 25 | $57.4M | $-180.4M | ||
| Q2 25 | $70.5M | $-115.0M | ||
| Q1 25 | $91.4M | $-151.1M | ||
| Q4 24 | $50.1M | $-133.2M | ||
| Q3 24 | $42.3M | $-133.5M | ||
| Q2 24 | $72.0M | $-131.6M | ||
| Q1 24 | $70.3M | $-170.7M |
毛利率BSYRARE
| Q4 25 | 81.9% | — | ||
| Q3 25 | 80.8% | — | ||
| Q2 25 | 81.1% | — | ||
| Q1 25 | 82.3% | — | ||
| Q4 24 | 80.6% | — | ||
| Q3 24 | 80.7% | — | ||
| Q2 24 | 80.9% | — | ||
| Q1 24 | 81.7% | — |
营业利润率BSYRARE
| Q4 25 | 20.0% | -54.7% | ||
| Q3 25 | 22.5% | -106.9% | ||
| Q2 25 | 23.2% | -64.8% | ||
| Q1 25 | 31.1% | -102.6% | ||
| Q4 24 | 17.6% | -74.3% | ||
| Q3 24 | 20.5% | -94.6% | ||
| Q2 24 | 24.3% | -79.1% | ||
| Q1 24 | 27.2% | -151.9% |
净利率BSYRARE
| Q4 25 | 15.0% | -62.0% | ||
| Q3 25 | 15.3% | -112.8% | ||
| Q2 25 | 19.4% | -69.0% | ||
| Q1 25 | 24.7% | -108.5% | ||
| Q4 24 | 14.3% | -80.9% | ||
| Q3 24 | 12.6% | -95.7% | ||
| Q2 24 | 21.8% | -89.5% | ||
| Q1 24 | 20.8% | -156.8% |
每股收益（稀释后）BSYRARE
| Q4 25 | $0.17 | $-1.28 | ||
| Q3 25 | $0.18 | $-1.81 | ||
| Q2 25 | $0.22 | $-1.17 | ||
| Q1 25 | $0.28 | $-1.57 | ||
| Q4 24 | $0.15 | $-1.34 | ||
| Q3 24 | $0.13 | $-1.40 | ||
| Q2 24 | $0.22 | $-1.52 | ||
| Q1 24 | $0.22 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $123.3M | $421.0M |
| 总债务越低越好 | $1.2B | — |
| 股东权益账面价值 | $1.2B | $-80.0M |
| 总资产 | $3.6B | $1.5B |
| 负债/权益比越低杠杆越低 | 1.05× | — |
8季度趋势，按日历期对齐
现金及短期投资BSYRARE
| Q4 25 | $123.3M | $421.0M | ||
| Q3 25 | $165.4M | $202.5M | ||
| Q2 25 | $89.6M | $176.3M | ||
| Q1 25 | $83.6M | $127.1M | ||
| Q4 24 | $64.0M | $174.0M | ||
| Q3 24 | $72.2M | $150.6M | ||
| Q2 24 | $51.3M | $480.7M | ||
| Q1 24 | $141.6M | $112.3M |
总债务BSYRARE
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.4B | — |
股东权益BSYRARE
| Q4 25 | $1.2B | $-80.0M | ||
| Q3 25 | $1.2B | $9.2M | ||
| Q2 25 | $1.2B | $151.3M | ||
| Q1 25 | $1.1B | $144.2M | ||
| Q4 24 | $1.0B | $255.0M | ||
| Q3 24 | $1.0B | $346.8M | ||
| Q2 24 | $984.5M | $432.4M | ||
| Q1 24 | $932.6M | $140.3M |
总资产BSYRARE
| Q4 25 | $3.6B | $1.5B | ||
| Q3 25 | $3.5B | $1.2B | ||
| Q2 25 | $3.4B | $1.3B | ||
| Q1 25 | $3.4B | $1.3B | ||
| Q4 24 | $3.4B | $1.5B | ||
| Q3 24 | $3.4B | $1.5B | ||
| Q2 24 | $3.3B | $1.6B | ||
| Q1 24 | $3.4B | $1.3B |
负债/权益比BSYRARE
| Q4 25 | 1.05× | — | ||
| Q3 25 | 1.04× | — | ||
| Q2 25 | 1.07× | — | ||
| Q1 25 | 1.13× | — | ||
| Q4 24 | 1.33× | — | ||
| Q3 24 | 1.37× | — | ||
| Q2 24 | 1.36× | — | ||
| Q1 24 | 1.54× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $141.6M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $136.2M | $-100.8M |
| 自由现金流率自由现金流/营收 | 34.8% | -48.6% |
| 资本支出强度资本支出/营收 | 1.4% | 0.5% |
| 现金转化率经营现金流/净利润 | 2.41× | — |
| 过去12个月自由现金流最近4个季度 | $520.2M | $-472.0M |
8季度趋势，按日历期对齐
经营现金流BSYRARE
| Q4 25 | $141.6M | $-99.8M | ||
| Q3 25 | $116.4M | $-91.4M | ||
| Q2 25 | $61.1M | $-108.3M | ||
| Q1 25 | $219.4M | $-166.5M | ||
| Q4 24 | $81.6M | $-79.3M | ||
| Q3 24 | $86.1M | $-67.0M | ||
| Q2 24 | $62.6M | $-77.0M | ||
| Q1 24 | $205.0M | $-190.7M |
自由现金流BSYRARE
| Q4 25 | $136.2M | $-100.8M | ||
| Q3 25 | $110.7M | $-92.7M | ||
| Q2 25 | $57.0M | $-110.7M | ||
| Q1 25 | $216.4M | $-167.8M | ||
| Q4 24 | $76.1M | $-79.5M | ||
| Q3 24 | $84.3M | $-68.6M | ||
| Q2 24 | $59.5M | $-79.0M | ||
| Q1 24 | $201.4M | $-193.9M |
自由现金流率BSYRARE
| Q4 25 | 34.8% | -48.6% | ||
| Q3 25 | 29.5% | -58.0% | ||
| Q2 25 | 15.7% | -66.5% | ||
| Q1 25 | 58.4% | -120.5% | ||
| Q4 24 | 21.7% | -48.3% | ||
| Q3 24 | 25.1% | -49.2% | ||
| Q2 24 | 18.0% | -53.7% | ||
| Q1 24 | 59.6% | -178.2% |
资本支出强度BSYRARE
| Q4 25 | 1.4% | 0.5% | ||
| Q3 25 | 1.5% | 0.8% | ||
| Q2 25 | 1.1% | 1.5% | ||
| Q1 25 | 0.8% | 1.0% | ||
| Q4 24 | 1.6% | 0.1% | ||
| Q3 24 | 0.5% | 1.2% | ||
| Q2 24 | 0.9% | 1.4% | ||
| Q1 24 | 1.1% | 3.0% |
现金转化率BSYRARE
| Q4 25 | 2.41× | — | ||
| Q3 25 | 2.03× | — | ||
| Q2 25 | 0.87× | — | ||
| Q1 25 | 2.40× | — | ||
| Q4 24 | 1.63× | — | ||
| Q3 24 | 2.03× | — | ||
| Q2 24 | 0.87× | — | ||
| Q1 24 | 2.92× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BSY
| Enterprise License Subscriptions | $163.4M | 42% |
| Term License Subscriptions | $122.7M | 31% |
| SELECT Subscriptions | $70.6M | 18% |
| Professional Services Other | $17.2M | 4% |
| Perpetual Licenses | $14.3M | 4% |
| Professional Services Recurring | $3.5M | 1% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
